Breakingviews: Elan's possible side effects (3:02)
Feb 6 - Antony Currie and Robert Cyran discuss how the tidy profit the company will reap from selling most of its stake in a top-selling drug to Biogen could make investors sick. ( Transcript )
Hard-edged reporting, insight and analysis, Reuters TV breaks ground creating informative news and financial videos. Showcasing Reuters’ 3000 award-winning journalists, Reuters TV delivers high-energy investigative journalism with concise explanations. Check it out and let us know what you think.